Appointment booking for Dr. Ramin Tolouian, MD is currently not available.Dr. Ramin Tolouian, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Ramin Tolouian, MD (he/him) is a Nephrologist in Norfolk, VA with over 18 years of experience. What is your opinion of Dr. Ramin Tolouian, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ramin Tolouian, MD has received over $222,548 which includes payments from the following companies:
$214,211.50 from GENZYME CORPORATION
$4,485.85 from Alexion Pharmaceuticals, Inc.
$1,500.00 from Retrophin, Inc.
$619.74 from Otsuka America Pharmaceutical, Inc.
$461.22 from Amgen Inc.
$337.75 from Questcor Pharmaceuticals
$197.08 from Bard Peripheral Vascular, Inc.
$129.95 from Pharmacosmos Therapeutics Inc.
$115.90 from Mallinckrodt LLC
$111.55 from Baxter Healthcare
$110.24 from The Binding Site Inc.
$102.32 from Novartis Pharmaceuticals Corporation
$87.83 from Fresenius USA Marketing, Inc.
$77.65 from OPKO Pharmaceuticals, LLC
Payments received by Dr. Ramin Tolouian, MD were from the following categories:
$138,910.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!